Jinniao Medical Secures Tens of Millions in Angel Funding Led by CDH Bofu and Shanghai State-Owned Investors for Invasive Brain-Computer Interface Development

Recently, JN Medtech (Shanghai Jinnao Medical Technology Co., Ltd.) completed an angel round of financing worth tens of millions.

This round of financing was led byCDH Investments led the investment, with participation from Shanghai Intellectual Property Fund, Shanghai Pudong Venture Investment Co., Ltd., and Zhangjiang Science & Technology Investment.Three Shanghai state-owned institutions followed the investment.

This round of funding will be mainly used forClinical Class III Medical Device: High-Density Ultra-Micro Array Electrode SystemThe development and clinical validation work to accelerate its progress towards medical device registration and market launch.

JN Medtech 2024 Founded in Zhangjiang Science City, Shanghai, byNational Engineering Research Center for Biochip ShanghaiIncubation,YesChina's Innovative Enterprise Focusing on Invasive Brain-Computer Interface，Focus on high-density neural acquisition and AI Decoding technology to address unmet clinical needs such as high-level paralysis, refractory epilepsy, and severe neuropsychiatric disorders.

JN MedtechIt is the first representative enterprise in China with ultra-micro array as its core technology route.，Adopting an innovative ultra-fine electrode wire design, it combines the dual advantages of flexibility and rigidity, aiming to achieve high acquisition efficiency, high biosafety, low-trauma and high-success-rate implantation, as well as long-term stable signal acquisition.

Its core product is the "High-Density Ultra-Micro Array Electrode System".This system"Three-Stage Design"，It specifically addresses the pain points of traditional invasive brain-computer interfaces—implanted probes:It is1600Root diameter is only10umThe ultra-fine electrode wire is integrated into a10x10mmArrayExploreHead, can be implanted into the motor cortex of the brain; analog-to-digital conversionHUB: IntegratedADCThe chip circuit can digitize the analog neural signals collected by the implanted probe in real time, and perform processing such as gain amplification, filtering, and analysis; Signal output and power supply module: capable of transmitting signals to an external receiver, while the battery embedded under the skin can provide long-term power.ADCPower supply to the circuit.This three-part structural design can perfectly address the limitations that invasive brain-computer interfaces have already encountered, such as energy consumption, heating, and electrode detachment.，In addition, this design has also been verified to have excellent efficacy and safety.

JN Medtech relies on a professional neuro-electrophysiological technology team and a systematic scientific research background,Focus on providing full-stack scientific research technical services for basic brain science research (CROResearch and Experimental Services, Focus onHospitals, Universities, Biopharmaceutical CompaniesProviding professional and systematic experimental services and technical training, the business scope includesResearch Protocol Design, Electrode Custom Production, Ex Vivo Localization Experiment Operation, Neural Signal Acquisition, Behavioral Experiment, Data Analysis and ReportSix aspects, covering all technical细分环节 of in vivo multi-channel neuro-electrophysiology.

JN MedtechCROThe proportion of master's degree holders in the experimental operation team is60%, the proportion of PhDs is40%, with extremely professional competence in the research field, each having no less than5Years of experience in brain experimental operations.

Founder of the company,CEO Feng Shiqing holds a Ph.D. in Neurobiology from East China Normal University and has worked as an Assistant Researcher at the Shanghai Mental Health Center.&Head of the Electrophysiology Lab, long-term engagement in invasive brain-computer interface scientific research,Using drivable invasive electrodes to study EEG mechanisms and memory formation projects.

CDH, as a top investment institution in China, led the investment in JN Medtech, reflecting its strong confidence in the cutting-edge track of implantable brain-computer interfaces. The three Shanghai state-owned institutions—Shanghai Intellectual Property Fund, Shanghai Pudong Venture Investment Co., Ltd., and Zhangjiang Science & Technology Investment—jointly participated in the investment, highlighting Shanghai's policy trend of accelerating the layout of future industry frontiers such as brain-computer interfaces.

JN Medtech believes,Brain-computer interface as"15th Five-Year Plan" Key Layout of Future Industries, a disruptive track that deeply integrates neuroscience, electronic materials, and computer science,Bearing the Strategic High Ground of Next-Generation Human-Machine Interaction and Life Science。

The industry has completed a century of technological accumulation and is now officiallyFrom the laboratory R&D stage to the initial phase of clinical implementation and industrial scale-up，Under the triple resonance of policy, technology, and capital,2026The year will become the critical point for the outbreak of the brain-computer interface industry.。

Recommended Reading